NCT00579098View on ClinicalTrials.gov

The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Atrial FibrillationArrhythmiaInflammationEndothelial Dysfunction
Interventions
DRUG

Atorvastatin

80 mg tablet taken by mouth daily for 90 days

DRUG

Placebo

Placebo tablet taken by mouth once daily for 90 days

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Mayo Clinic

OTHER

NCT00579098 - The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation | Biotech Hunter | Biotech Hunter